A Study of Dietary Patterns Derived by Cluster Analysis and Their Association With Metabolic Dysfunction-Associated Steatotic Liver Disease Severity Among Hispanic Patients

被引:0
|
作者
Zhang, Xiaotao [1 ,2 ,3 ]
Daniel, Carrie R. [1 ]
Soltero, Valeria [4 ]
Vargas, Ximena [4 ]
Jain, Shilpa [5 ]
Kanwal, Fasiha [4 ,6 ]
Thrift, Aaron P. [7 ,8 ]
Balakrishnan, Maya [4 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Div Canc Prevent & Populat Sci, Houston, TX USA
[2] Icahn Sch Med Mt Sinai, Inst Translat Epidemiol, New York, NY USA
[3] Icahn Sch Med Mt Sinai, Dept Med, Div Liver Dis, New York, NY USA
[4] Baylor Coll Med, Dept Internal Med, Sect Gastroenterol & Hepatol, Houston, TX 77030 USA
[5] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX USA
[6] Michael E DeBakey VA Med Ctr, Houston VA HSR&D Ctr Innovat Qual Effectiveness &, Dept Internal Med, Houston, TX USA
[7] Baylor Coll Med, Dept Med, Sect Epidemiol & Populat Sci, Houston, TX USA
[8] Baylor Coll Med, Dan L Duncan Comprehens Canc Ctr, Houston, TX USA
关键词
MASLD; hepatic steatosis; dietary pattern; nutrition; diet; dietary cluster analysis; MEDITERRANEAN DIET; HEPATIC STEATOSIS; PRACTICE GUIDANCE; MANAGEMENT; ADHERENCE; FIBROSIS; FAT;
D O I
10.14309/ajg.0000000000002508
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
INTRODUCTION:Diet is a modifiable metabolic dysfunction-associated steatotic liver disease (MASLD) risk factor, but few studies have been conducted among Hispanic patients, despite the fact that MASLD prevalence and severity are highest among this ethnic subgroup. We aimed to identify prevalent dietary patterns among Hispanic patients using cluster analysis and to investigate associations with MASLD severity.METHODS:This cross-sectional analysis included 421 Harris County MASLD Cohort participants who self-reported Hispanic ethnicity and completed baseline food frequency questionnaires. All included patients had MASLD, diagnosed per standard clinical criteria. K-means analysis was used to identify clusters of patients sharing similar dietary habits. Multivariable adjusted logistic regression was used to estimate associations of dietary clusters with aminotransferases among the overall sample and with histologic steatosis, metabolic dysfunction-associated steatohepatitis, and fibrosis among a subsample of patients who underwent liver biopsy within 6 months of their baseline food frequency questionnaire (n = 186).RESULTS:We identified 2 clusters: a plant-food/prudent and a fast-food/meat pattern. The fast-food/meat pattern was associated with 2.47-fold increased odds (95% confidence interval 1.31-4.65) of more severe steatosis than the plant-food/prudent pattern after adjusting for demographics, metabolic score, physical activity, and alcohol (q = 0.0159). No significant association was observed between diet and aminotransferases, metabolic dysfunction-associated steatohepatitis, or fibrosis.DISCUSSION:Given the importance of sociocultural influences on diet, it is important to understand dietary patterns prevalent among Hispanic patients with MASLD. Using cluster analysis, we identified 1 plant-based pattern vs 1 distinct fast-food/meat-based pattern associated with detrimental effects among our population. This information is an important starting point for tailoring dietary interventions for Hispanic patients with MASLD.
引用
收藏
页码:505 / 511
页数:7
相关论文
共 50 条
  • [21] Sexual dimorphism of metabolic dysfunction-associated steatotic liver disease
    Cherubini, Alessandro
    Della Torre, Sara
    Pelusi, Serena
    Valenti, Luca
    TRENDS IN MOLECULAR MEDICINE, 2024, 30 (12) : 1126 - 1136
  • [22] Metabolic Dysfunction-Associated Steatotic Liver Disease: An Overview of Pharmacotherapy
    El Hussein, Mohamed
    Favell, Daniel
    JNP- THE JOURNAL FOR NURSE PRACTITIONERS, 2025, 21 (02):
  • [23] Non-invasive testing in metabolic dysfunction-associated steatotic liver disease
    Dawod, Sanad
    Brown, Kimberly
    FRONTIERS IN MEDICINE, 2024, 11
  • [24] Metabolic Dysfunction-Associated Steatotic Liver Disease: Pathogenetic Links to Cardiovascular Risk
    Ionescu, Vlad Alexandru
    Gheorghe, Gina
    Bacalbasa, Nicolae
    Diaconu, Camelia Cristina
    BIOMOLECULES, 2025, 15 (02)
  • [25] Menopause and metabolic dysfunction-associated steatotic liver disease
    Polyzos, Stergios A.
    Goulis, Dimitrios G.
    MATURITAS, 2024, 186
  • [26] Active role of the immune system in metabolic dysfunction-associated steatotic liver disease
    Mori, Taizo
    Yoshio, Sachiyo
    Kakazu, Eiji
    Kanto, Tatsuya
    GASTROENTEROLOGY REPORT, 2024, 12
  • [27] Association Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Thyroid Cancer
    Moon, Sang Yi
    Son, Minkook
    Cho, Jung-Hwan
    Kim, Hye In
    Han, Ji Min
    Bae, Ji Cheol
    Suh, Sunghwan
    THYROID, 2025, 35 (01) : 79 - 86
  • [28] Disparate outcomes in Hispanic patients with metabolic dysfunction-associated steatotic liver disease/steatohepatitis and type 2 diabetes: Large cohort study
    Gosnell, Joseph Matthew
    Golovko, George
    Arroyave, Esteban
    Moghe, Akshata
    Kueht, Michael L.
    Saldarriaga, Omar Abdul
    Mckinney, Kevin H.
    Stevenson, Heather L.
    Ferguson, Monique R.
    WORLD JOURNAL OF DIABETES, 2024, 15 (05)
  • [29] The Association Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Change in Liver Stiffness in Patients With Chronic Hepatitis B
    Patmore, Lesley A.
    van Eekhout, Kirsi
    Koc, oezguer M.
    de Knegt, Robert J.
    Janssen, Harry L. A.
    Brouwer, Willem P.
    Kramer, Matthijs
    Honkoop, Pieter
    de Bruijne, Joep
    Boland, Greet J.
    Postma, Douwe F.
    Blokzijl, Hans
    de Man, Robert A.
    Takkenberg, R. Bart
    Sonneveld, Milan J.
    LIVER INTERNATIONAL, 2025, 45 (03)
  • [30] The bidirectional immune crosstalk in metabolic dysfunction-associated steatotic liver disease
    Sawada, Keisuke
    Chung, Hak
    Softic, Samir
    Moreno-Fernandez, Maria E.
    Divanovic, Senad
    CELL METABOLISM, 2023, 35 (11) : 1852 - 1871